Answers are grounded in this paper and cite their sources.
Topically administered bevacizumab (Avastin) at a concentration of 4 mg/ml limits corneal neovascularisation following chemical injury in the male Long Evans rat model.
No takes yet. Share an insight, caveat, or question.
Manzano et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: